Loomis, Sayles & Company
OPK icon

Loomis, Sayles & Company’s Opko Health OPK Stock Holding History

Loomis, Sayles & Company’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed – – 1098
2015
Q3 		$0 Buy
+2
New +$26 ﹤0.01% 1054

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company's OPK Position: Q4 2015 in Review

Loomis, Sayles & Company sold out of Opko Health (OPK) in Q4 2015, closing a stake of 2 shares.

Loomis, Sayles & Company first reported a position in OPK in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 273 funds tracked by Wall St. Rank hold OPK as of Q4 2015.

  • Loomis, Sayles & Company reported no remaining Opko Health position as of Q4 2015 after selling out during the quarter.
  • Loomis, Sayles & Company sold 2 Opko Health shares in Q4 2015.
  • Loomis, Sayles & Company first reported a position in Opko Health in Q3 2015 and held it in 1 quarter.
  • Loomis, Sayles & Company's Opko Health position peaked at $0 in Q3 2015.
  • 273 funds tracked by Wall St. Rank held Opko Health as of Q4 2015.

Based on Loomis, Sayles & Company's 13F filing for Q4 2015, filed 12 Feb 2016.